Howard Prentice

Howard Prentice, Ph.D., is a Professor of Biomedical Science at the Charles E. Schmidt College of Medicine, Florida Atlantic University, with a focus on neuroprotection, gene therapy, and hypoxia-related molecular pathways. His career spans institutions including Stanford University, University of Glasgow, and University of Southern California.

• Ph.D. in Biochemistry (1987), University of London
• Postdoctoral work under Dr. Larry Kedes at Stanford and USC
• Faculty roles at University of Glasgow (1993-2000) and FAU (2000-present)

Dr. Prentice's research explores neuroprotective interventions for stroke, retinal disease, and ischemic injuries. Key themes include taurine's neuroprotective mechanisms, hypoxia-regulated gene therapy, and pharmacological preconditioning. His work bridges molecular biology and translational applications, with patents in stroke therapies.

Recent publications emphasize taurine's role in mitigating ER stress, anti-apoptotic gene therapy, and anoxia tolerance mechanisms. Collaborative studies span institutions like Harvard Medical School and University of Miami.

• 2015: Organizing Committee, Global Summit on Stroke
• 2009: Excellence in Teaching, FAU
• 2007: Dwight W. Warren Award for Graduate Teaching

Dr. Prentice holds secondary appointments in Biological Sciences (FAU) and Molecular and Cellular Pharmacology (University of Miami), and participates in interdisciplinary centers including the Center for Complex Systems and Brain Sciences.